BEIGF:OTCMKTS
BeOne Medicines
21,95 $
0,00%
(0,00) 1 d.
9. jūn., 12:49:46 GMT-4 · USD
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: BEIGF…
Tirgus kapitalizācija
42,40 mljrd.
Vid. apjoms
0,00
Apjoms
0,00
Augstākā 52 ned.
24,92 $
Zemākā 52 ned.
21,95 $
Beta
0,84
Apgrozībā esošās akcijas
1,43 mljrd.
Darbinieku skaits
12 tūkst.
Tirgus kapitalizācija
42,40 mljrd.
Vid. apjoms
0,00
Apjoms
0,00
Augstākā 52 ned.
24,92 $
Zemākā 52 ned.
21,95 $
Beta
0,84
Apgrozībā esošās akcijas
1,43 mljrd.
Darbinieku skaits
12 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
CNBC
·
pirms 55 minūtēm
Jim Cramer says the bull market's remarkable 4-year run offers a crucial lesson for investors
New York Post
·
pirms 26 minūtēm
NYSE's opening bell honors Italian Americans who beat stereotypes to reach pinnacle of finance
Simply Wall Street
·
pirms 1 stundas
Qualcomm (QCOM) Makes Its AI Infrastructure Pivot Harder To Ignore
Yahoo Finance
·
pirms 5 stundām
Not Sandisk, Not Intel. This Stock Will Lead the S&P 500 Next Year
Profils
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
Founded in 2010 by chief executive officer John V. Oyler and Xiaodong Wang, the company is headquartered in Cambridge, Massachusetts and has locations on six continents, in over 45 countries. BeOne has a large presence in the Chinese market.
BeOne Medicines has developed several medicines, including tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Bruton's tyrosine kinase inhibitor. On 14 November 2024, the company announced its intention to rebrand as BeOne Medicines. BeOne changed its stock ticker to ONC in January 2025 and redomiciled to Basel, Switzerland in May 2025. Wikipedia
Par “BeOne Medicines”
ĢenerāldirektorsJohn Vincent Oyler | John Vincent Oyler
Darbinieki12 tūkst.
Dibināšanas datums2010. gada 28. okt.
Galvenais birojs-
Sektors-
Tīmekļa vietnebeonemedicines.com